| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/22/1999 | WO1999036064A2 Methods of treating tardive dyskinesia and other movement disorders |
| 07/22/1999 | WO1999022724A3 Extended release formulation containing venlafaxin |
| 07/22/1999 | DE19801647A1 New beta, gamma-fused lactone glutamate receptor modulators for treating cerebral ischemia, cranial or brain trauma, pain or CNS-mediated spasms |
| 07/22/1999 | DE19801646A1 New bicyclic lactone glutamate receptor modulators for treating cerebral ischemia, cranial/brain trauma, pain or CNS-mediated spasms |
| 07/22/1999 | DE19801636A1 New bi:cyclic lactone glutamate receptor modulators |
| 07/22/1999 | CA2318555A1 Thiophene nitrone compounds |
| 07/22/1999 | CA2318357A1 Thioether furan nitrone compounds |
| 07/22/1999 | CA2318279A1 Analgesic from snake venom |
| 07/22/1999 | CA2318195A1 Il-8 receptor antagonists |
| 07/22/1999 | CA2318037A1 Methods of neuroendocrine regulation of affective disorders |
| 07/22/1999 | CA2317813A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/22/1999 | CA2317760A1 Piperazino derivatives as neurokinin antagonists |
| 07/22/1999 | CA2317671A1 St. john's wort and methyl donor composition and uses thereof |
| 07/22/1999 | CA2317536A1 Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels |
| 07/22/1999 | CA2315219A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/22/1999 | CA2309546A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1.beta. converting enzyme (ice) |
| 07/21/1999 | EP0930302A2 Benzosulfone derivatives |
| 07/21/1999 | EP0930070A1 Stable aspirin ointment preparations |
| 07/21/1999 | EP0929671A1 Method for treating amyotrophic lateral sclerosis |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929574A1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS |
| 07/21/1999 | EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 07/21/1999 | EP0929569A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 07/21/1999 | EP0929568A2 Pharmaceutical compositions for the treatment of immune disorders |
| 07/21/1999 | EP0929554A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 07/21/1999 | EP0929550A1 $i(N)-(BENZOTHIAZOL-2-YL) PIPERIDINE-1-ETHANAMINE DERIVATIVES, THEIR PREPARATION AND APPLICATION IN THERAPEUTICS |
| 07/21/1999 | EP0929537A1 Troponyl piperazines as selective dopamine d4 receptor ligands |
| 07/21/1999 | EP0929528A1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/21/1999 | EP0929525A2 Novel heteroaryloxyethylamines, method of preparation, application as medicine and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929521A1 Nmda (n-methyl-d-aspartate) antagonists |
| 07/21/1999 | EP0929516A1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 07/21/1999 | EP0929515A1 Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 07/21/1999 | EP0929313A1 Regulation of neural enzymes |
| 07/21/1999 | EP0929303A2 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agent |
| 07/21/1999 | EP0929301A2 Controlled release dosage form of r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2]oct-3-yl)acetonitrile monohydrochloride |
| 07/21/1999 | EP0929299A1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA(b)BENZOFURANS |
| 07/21/1999 | EP0929298A1 Pharmaceutical compositions comprising s-(-)-n-propargyl-1-amino indan |
| 07/21/1999 | EP0765327B1 Pyrazolo and pyrrolopyridines |
| 07/21/1999 | EP0759025B1 Amide derivatives and their therapeutic use |
| 07/21/1999 | EP0750621B1 Heterocyclic compounds, their preparation and use |
| 07/21/1999 | EP0609441B1 Oxazolidone derivatives as monoamine oxidase inhibitors |
| 07/21/1999 | CN1223651A Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 07/21/1999 | CN1223641A Aryl pyrimidine derivatives |
| 07/21/1999 | CN1223583A Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders |
| 07/21/1999 | CN1223582A Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
| 07/21/1999 | CN1223574A Isobutylgaba and its derivatives for the treatment of pain |
| 07/21/1999 | CN1223141A Liquor for treating rheumatism and arthritis |
| 07/21/1999 | CN1044245C Tricyclic dicarbonyl derivatives, medicinal compositions and use thereof |
| 07/21/1999 | CN1044244C 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT 1A-antagonistic activity |
| 07/21/1999 | CN1044242C Heterocyclic-cyclic amine derivatives |
| 07/20/1999 | US5925782 Synthetic excitatory amino acids |
| 07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 07/20/1999 | US5925680 Synthetic excitatory amino acids |
| 07/20/1999 | US5925678 Use of N-acyl derivatives of aminoalcohols in the manufacture of a medicament for practicing neuroprotective action in neuropathological states connected with excitotoxicity |
| 07/20/1999 | US5925668 Thioctic metabolites and methods of use thereof |
| 07/20/1999 | US5925665 Imidazoline compounds |
| 07/20/1999 | US5925663 Benzimidazole derivatives |
| 07/20/1999 | US5925662 Compounds derived from oxazolidin-2-one and preparation and therapeutical use thereof |
| 07/20/1999 | US5925661 Nervous system disorders |
| 07/20/1999 | US5925650 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations |
| 07/20/1999 | US5925636 Inhibitors of tumor necrosis factor, phosphodiesterase |
| 07/20/1999 | US5925630 Neuroactive steroids of the androstane and pregnane series |
| 07/20/1999 | US5925627 Use of NK-1 receptor antagonists for treating movement disorders |
| 07/20/1999 | US5925521 Human serine carboxypeptidase |
| 07/20/1999 | US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 07/20/1999 | CA2162919C Rectal compositions |
| 07/20/1999 | CA2146367C Calcium channel blocking polypeptides from heteropoda venatoria |
| 07/20/1999 | CA2007200C 2-aminopyrimidinone derivatives |
| 07/20/1999 | CA1340667C Peptides having bradykinin antagonist action |
| 07/16/1999 | CA2258454A1 Benzosulfone derivatives |
| 07/15/1999 | WO1999035266A2 Human urotensin ii |
| 07/15/1999 | WO1999035253A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035247A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd |
| 07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035163A1 Phenylalanine derivatives |
| 07/15/1999 | WO1999035144A1 7-[(piperidin-1-yl)-propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use |
| 07/15/1999 | WO1999035131A1 Aryl fused azapolycyclic compounds |
| 07/15/1999 | WO1999035130A1 2,3-substituted indole compounds as cox-2 inhibitors |
| 07/15/1999 | WO1999035125A1 Alpha-aminoamide derivatives useful as analgesic agents |
| 07/15/1999 | WO1999035123A1 Substituted 2-benzylamino-2-phenyl-acetamide compounds |
| 07/15/1999 | WO1999035116A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
| 07/15/1999 | WO1999034834A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/15/1999 | WO1999034827A1 Activated t-cells and their uses |
| 07/15/1999 | WO1999034797A1 Method for treating multiple sclerosis |
| 07/15/1999 | WO1999034785A2 Treatment of dyskinesias |
| 07/15/1999 | WO1999034782A1 Tts containing an antioxidant |
| 07/15/1999 | WO1999034670A1 Gene mutant animals |
| 07/15/1999 | WO1999025716A3 Pyranones, method for the production and use thereof |
| 07/15/1999 | WO1999024026A3 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds |
| 07/15/1999 | CA2317811A1 Treatment of dyskinesias |
| 07/15/1999 | CA2317809A1 Gene mutant animals |
| 07/15/1999 | CA2317548A1 Method for treating multiple sclerosis |
| 07/15/1999 | CA2317382A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316973A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316864A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316863A1 2,3-substituted indole compounds as cox-2 inhibitors |
| 07/15/1999 | CA2282596A1 7-[(piperidin-1-yl)-propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use |
| 07/15/1999 | CA2245909A1 Novel compounds |
| 07/14/1999 | EP0928792A2 Bicyclic(3.1.0)hexanes and related compounds |